Results 91 to 100 of about 48,373 (242)

Diagnostic Delay in Pediatric Nasopharyngeal Burkitt Lymphoma Presenting With Chronic Otalgia and Multiple Cranial Nerve Palsies: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Persistent unilateral otalgia, especially when refractory to treatment and associated with cranial nerve signs, should prompt early imaging and nasopharyngeal evaluation to avoid delayed diagnosis of aggressive malignancies such as Burkitt lymphoma.
Sultaneh Haddad   +9 more
wiley   +1 more source

Features of combined (hbv/hcv-infection) viral lesion of the liver

open access: yesТерапевтический архив, 2008
Aim. To study clinical, biochemical features, course of combined viral hepatitides, dominant viral activity in combination HBV/HCV infection. Material and methods.
I V Maev   +3 more
doaj  

Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.

open access: yesIntervirology, 2010
Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests.
Veropalumbo E.   +12 more
openaire   +5 more sources

Dark Streaks and Yellow Exudates: Pleuroscopic Clues in Recurrent Post‐Traumatic Pleural Effusion

open access: yesRespirology Case Reports, Volume 14, Issue 10, October 2026.
We report the case of a 44‐year‐old male presenting 2 years after a road traffic accident, requiring emergency splenectomy, left diaphragmatic repair and tube thoracostomy, with a recurrent left‐sided hemorrhagic, exudative, lymphocytic pleural effusion.
Ali Gohar   +5 more
wiley   +1 more source

A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 7, Page 951-964, October 2026.
Cirrhosis patients with untreated HBV in Ethiopia exhibit a distinct immune profile marked by depletion of NK cells, B cells, and T cells, alongside an expanded CD38+HLA‐DR+ CD8 T‐cell population. ABSTRACT Background and Aims The immune cell phenotype of African patients living with chronic hepatitis B virus (HBV) infection is rarely described, despite
Julia MacLeod   +9 more
wiley   +1 more source

Antiviral Therapy and Post‐Resection Outcomes in Patients With Hepatitis B Virus‐Related Hepatocellular Carcinoma

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1123-1134, October 2026.
In 902 patients with HBV‐related HCC undergoing curative resection, antiviral regimens (ETV, TDF, TAF) showed comparable recurrence‐free survival. However, TDF was independently associated with improved overall survival compared with ETV. ABSTRACT Background & Aims The comparative outcomes of entecavir (ETV), tenofovir disoproxil fumarate (TDF), and ...
Jaehong Jeong   +10 more
wiley   +1 more source

Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case‐Notes Review

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 10, October 2026.
ABSTRACT Viral hepatitis mortality is an impact target required to evidence the elimination of viral hepatitis with a combined mortality rate of less than or equal to six deaths per 100,000 population. Within England, routine healthcare data linked with death registrations are used; however, where these data are not available, the World Health ...
David Etoori   +15 more
wiley   +1 more source

Hyperendemicity and genotype diversity of hepatitis B virus among patients attending the University of Abuja Teaching Hospital, Nigeria

open access: yesGMS Hygiene and Infection Control
Background: Hepatitis B virus (HBV) infection remains a significant global public health issue, particularly in sub-Saharan Africa, due to inadequate healthcare and research into its genetic epidemiology. This study aims to determine the frequency of HBV
Ugwu, Chinwe Ndidi   +14 more
doaj   +1 more source

EuroHePP: The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030.
Serena Fondelli   +23 more
wiley   +1 more source

Programmable Nanobody‐Targeting Chimeras Enable Intracellular Viral Protein Degradation

open access: yesAdvanced Science, Volume 13, Issue 53, 24 September 2026.
Nab‐TAC enables targeted degradation of HBV surface antigen (HBsAg) in vivo. By fusing nanobody‐based recognition domains with programmable proteasome‐recruiting degradation signals, Nab‐TAC reduces HBsAg levels in a hydrodynamic HBV mouse model. ABSTRACT Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because
Max Yu‐Chen Pan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy